ReGenX Biosciences

Pfizer, J&J sign on to streamline gene therapy development

A cadre of pharmas have signed on to a new U.S. federal government initiative to go after gene therapies for rare diseases, with $76 million in funds.

Annalee Armstrong Oct 28, 2021 9:55am

Abeona bags rights to Regenxbio AAV9 vector

Nov 5, 2018 10:21am

RegenXBio adds another CNS program to gene therapy plans

Aug 30, 2018 10:32am

Regenxbio’s wet AMD gene therapy shows promise in phase 1

Aug 8, 2018 10:55am

Ruhman joins NewcrestImage with more than 20 years of hospitality experience in senior management positions

Regenxbio to buy battered Dimension for gene therapies

Aug 25, 2017 9:04am